Skip to content

Inspection Record

Jubilant HollisterStier LLC — FDA 483 Findings

US FDAInspected 2026-06-17Published 2026-10-20 8 findingsQuality unit oversightDeviation, CAPA, and investigationLaboratory and QC controlsMaterial and supplier controlEquipment and facility

Inspectors Katherine E Jacobitz · Walden H Lee · Homero W Aguilar and 1 moreThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Quality unit oversight

The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed.

2Deviation, CAPA, and investigation

Written records of investigations into unexplained discrepancies do not always include the conclusions and follow-up.

3Laboratory and QC controls

Established test procedures are not followed.

4Laboratory and QC controls

Laboratory controls do not include the establishment of scientifically sound and appropriate sampling plans designed to assure that components conform to appropriate standards of identity, strength, quality and purity.

5Material and supplier control

Component testing is deficient in that each component is not tested for conformity with all appropriate written specifications for purity, strength, and quality.

6Material and supplier control

Written procedures are not followed for the storage of components.

7Equipment and facility

Equipment used in the manufacture, processing, packing or holding of drug products is not of appropriate design to facilitate operations for its intended use.

8Laboratory and QC controls

The sensitivity of test methods have not been established.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2026-10-20. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Other records for this company

Jubilant HollisterStier LLC findings history — including this company's other documentsAll US FDA findings US FDA documents, 2026 Go to Findings search
Linked from (backlinks)
Briefs that featured this document
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.